← Leaderboards
Christopher Benz
University Of California San Francisco
$17,978,842
Attributed
$23,370,233
Total exposure
14
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,370,233 · 14
By mechanism
U24$10,782,782 · 2
R01$9,739,534 · 4
P50$2,068,190 · 2
R21$464,145 · 1
P01$233,018 · 1
P41$82,564 · 4
Top collaborators
- David H Haussler9 shared
- Joshua Michael Stuart5 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Deborah G Grady$26,009,871
Others in their field
Top investigators on “Breast Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$347,312,063
- Norman Wolmark · Nsabp Foundation, Inc.$251,848,784
- Richard L Schilsky · University Of Chicago$110,812,897
- Walter John Curran · Thomas Jefferson University$96,881,565
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$87,504,493
- Monica M Bertagnolli · Strang Cancer Prevention Center$84,613,341
Research focus
Breast NeoplasmsBaseTumorMolecularSamplingGene ExpressionClinical TrialsEstrogen ReceptorsCell LineResearch PersonnelMalignant NeoplasmsNeoplasm /Cancer ChemotherapyResponseCancer TherapyGenomicsOxidative StressPathway InteractionsInsightProtein IsoformsPreventGleanHuman TissueMachine LearningBiological
Grant awards (64)
UCSC-Buck Genome Data Analysis Center for the Genomic Data Analysis Network v2.0$385,872
U24 · FY2025 · CA
UCSC-Buck Genome Data Analysis Center for the Genomic Data Analysis Network v2.0$366,578
U24 · FY2024 · CA
UCSC-Buck Genome Data Analysis Center for the Genomic Data Analysis Network v2.0$366,225
U24 · FY2023 · CA
UCSC-Buck Genome Data Analysis Center for the Genomic Data Analysis Network v2.0$378,154
U24 · FY2022 · CA
Mouse oocyte fate determination via polarized cytoplasmic transport within germline cysts$65,318
R01 · FY2022 · GM · contact PI
UCSC-Buck Genome Data Analysis Center for the Genomic Data Analysis Network v2.0$412,872
U24 · FY2021 · CA
Mouse oocyte fate determination via polarized cytoplasmic transport within germline cysts$407,400
R01 · FY2021 · GM · contact PI
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)$143,442
U24 · FY2016 · CA
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)$1,000,000
U24 · FY2014 · CA
Mass spectrometry to decode PTM patterns and enhance the Biomarker utility of ER$333,416
R01 · FY2014 · CA · contact PI
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)$316,000
U24 · FY2014 · CA
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)$1,877,957
U24 · FY2013 · CA
Mass spectrometry to decode PTM patterns and enhance the Biomarker utility of ER$323,103
R01 · FY2013 · CA · contact PI
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)$1,309,530
U24 · FY2012 · CA
Mass spectrometry to decode PTM patterns and enhance the Biomarker utility of ER$343,727
R01 · FY2012 · CA · contact PI
Polyribosome targets mediating mRNA decay for cancer prediction and therapy$253,170
R21 · FY2012 · CA · contact PI
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)$1,312,129
U24 · FY2011 · CA
Mass spectrometry to decode PTM patterns and enhance the Biomarker utility of ER$343,727
R01 · FY2011 · CA · contact PI
Polyribosome targets mediating mRNA decay for cancer prediction and therapy$210,975
R21 · FY2011 · CA · contact PI
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)$1,084,905
U24 · FY2010 · CA
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)$829,118
U24 · FY2010 · CA
Mass spectrometry to decode PTM patterns and enhance the Biomarker utility of ER$157,493
R01 · FY2010 · CA · contact PI
UCSC-Buck Inst. Genome Data Analysis Center for TCGA Research Network (GDAC)$1,000,000
U24 · FY2009 · CA
Defective Estrogen Receptors in Breast Tumors$305,812
R01 · FY2008 · CA · contact PI
CLINICAL SIGNIFICANCE OF FUNCTIONALLY DEFECTIVE ESTROGEN RECEPTOR$5,934
P41 · FY2008 · RR · contact PI
Biology of Breast Cancers Arising in Older Women$558,296
R01 · FY2007 · AG · contact PI
Therapeutic Modulation of Breast Cancer Oncogenes$321,908
R01 · FY2007 · CA · contact PI
Defective Estrogen Receptors in Breast Tumors$305,812
R01 · FY2007 · CA · contact PI
CLINICAL SIGNIFICANCE OF FUNCTIONALLY DEFECTIVE ESTROGEN RECEPTOR$25,154
P41 · FY2007 · RR · contact PI
Biology of Breast Cancers Arising in Older Women$560,556
R01 · FY2006 · AG · contact PI
Therapeutic Modulation of Breast Cancer Oncogenes$331,522
R01 · FY2006 · CA · contact PI
Defective Estrogen Receptors in Breast Tumors$314,945
R01 · FY2006 · CA · contact PI
CLINICAL SIGNIFICANCE OF FUNCTIONALLY DEFECTIVE ESTROGEN RECEPTOR$13,214
P41 · FY2006 · RR · contact PI
Biology of Breast Cancers Arising in Older Women$564,728
R01 · FY2005 · AG
Therapeutic Modulation of Breast Cancer Oncogenes$339,500
R01 · FY2005 · CA
Defective Estrogen Receptors in Breast Tumors$322,525
R01 · FY2005 · CA
ECOLOGICAL &CLIN SIG OF DEFECTIVE ESTROGEN RECEPTOR FROM HUMAN BREAST TUMOR$20,503
P41 · FY2005 · RR
Biology of Breast Cancers Arising in Older Women$555,085
R01 · FY2004 · AG
Therapeutic Modulation of Breast Cancer Oncogenes$339,500
R01 · FY2004 · CA
Defective Estrogen Receptors in Breast Tumors$322,525
R01 · FY2004 · CA
ECOLOGICAL &CLIN SIG OF DEFECTIVE ESTROGEN RECEPTOR$17,759
P41 · FY2004 · RR
Biology of Breast Cancers Arising in Older Women$562,420
R01 · FY2003 · AG
Therapeutic Modulation of Breast Cancer Oncogenes$339,500
R01 · FY2003 · CA
DEFECTIVE ESTROGEN RECEPTORS IN BREAST TUMORS$265,173
R01 · FY2003 · CA
THERAPEUTIC MODULATION OF BREAST CANCER ONCOGENES$264,013
R01 · FY2002 · CA
DEFECTIVE ESTROGEN RECEPTORS IN BREAST TUMORS$259,085
R01 · FY2002 · CA
DEVELOPMENT OF MEMBRANE RECEPTOR TARGETED AND TUMORICIDAL BREAST CANCER THERAPY$206,819
P50 · FY2002 · CA
DEVELOPMENT OF MEMBRANE RECEPTOR TARGETED AND TUMORICIDAL BREAST CANCER THERAPY$206,819
P50 · FY2002 · CA
DEVELOPMENTAL RESEARCH PROGRAM--BREAST CANCER$206,819
P50 · FY2002 · CA
DEVELOPMENTAL RESEARCH PROGRAM--BREAST CANCER$206,819
P50 · FY2002 · CA
DEFECTIVE ESTROGEN RECEPTORS IN BREAST TUMORS$26,679
R01 · FY2002 · CA
THERAPEUTIC MODULATION OF BREAST CANCER ONCOGENES$249,891
R01 · FY2001 · CA
DEFECTIVE ESTROGEN RECEPTORS IN BREAST TUMORS$245,344
R01 · FY2001 · CA
DEVELOPMENT OF MEMBRANE RECEPTOR TARGETED AND TUMORICIDAL BREAST CANCER THERAPY$206,819
P50 · FY2001 · CA
DEVELOPMENTAL RESEARCH PROGRAM--BREAST CANCER$206,819
P50 · FY2001 · CA
DEVELOPMENTAL RESEARCH PROGRAM--BREAST CANCER$206,819
P50 · FY2001 · CA
DEVELOPMENT OF MEMBRANE RECEPTOR TARGETED AND TUMORICIDAL BREAST CANCER THERAPY$206,819
P50 · FY2001 · CA
ACTIVATION OF ONCOGENES AND RECEPTORS IN HUMAN BREAST CANCER--ETS AND HER2/NEU$233,018
P01 · FY2000 · CA
DEVELOPMENTAL RESEARCH PROGRAM--BREAST CANCER$206,819
P50 · FY2000 · CA
DEVELOPMENT OF MEMBRANE RECEPTOR TARGETED AND TUMORICIDAL BREAST CANCER THERAPY$206,819
P50 · FY2000 · CA
THERAPEUTIC MODULATION OF BREAST CANCER ONCOGENES$176,521
R01 · FY2000 · CA
DEFECTIVE ESTROGEN RECEPTORS IN BREAST TUMORS$124,213
R01 · FY2000 · CA
DEFECTIVE ESTROGEN RECEPTORS IN BREAST TUMORS$90,677
R01 · FY2000 · CA
THERAPEUTIC MODULATION OF BREAST CANCER ONCOGENES$19,120
R01 · FY2000 · CA